AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.000
-0.090 (-8.26%)
Apr 23, 2026, 2:13 PM EDT - Market open
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $25.3 million as of April 23, 2026. Its market cap has increased by 476.65% in one year.
Market Cap
25.30M
Enterprise Value
60.32M
1-Year Change
476.65%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $25.30M, a decrease of -60.25%. That is a compound annual growth rate of -16.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 27.58M | 111.79% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 29.68M |
| Apollomics | 29.05M |
| Marker Therapeutics | 27.84M |
| Tempest Therapeutics | 27.83M |
| NanoViricides | 27.64M |
| Neuphoria Therapeutics | 27.12M |
| Skye Bioscience | 26.15M |
| Psyence Biomedical | 25.91M |